COVID-19

Outside of the loss of human life due to the COVID-19 pandemic, the past two years have greatly affected hospitals, health systems and the way providers deliver care. Healthcare executives are grappling with federal monetary assistance, growing burnout rates, workforce shortages and federal oversight of vaccines and testing. This channel is also designed to update clinicians on new research and guidelines regarding COVID patient treatment strategies and risk assessments.

US doctors still bouncing back from COVID-era burnout
Physician burnout rates continue to fall, and the healthy trend comes alongside strong and stable rates of physician job satisfaction.
To optimize infection-control practices, know your providers’ priorities
Demonstrated cost-effectiveness is a highly motivating factor in getting healthcare workers to adopt measures for preventing and controlling healthcare-associated infections.
ACIP panel given new guidance to shape vaccine recommendations
The shift comes after a federal court struck down sweeping changes to the pediatric vaccine schedule that went into effect in 2026. The committee of medical experts, which advises on policy at the Centers for Disease Control and Prevention (CDC), will have to focus on a cost-benefit analysis in its future analyses.
How telehealth utilization among heart patients has evolved since the pandemic
The COVID-19 pandemic created a major shift in how telehealth services were being utilized. Those services were used much more often for some patient populations than others.
ACIP meeting postponed after judge pauses RFK’s new vaccine recommendations
Judge Brian Murphy with the U.S. District Court of Massachusetts sided with the American Academy of Pediatrics and other plaintiffs who challenged the authority of HHS Secretary Robert F. Kennedy Jr to effectively remove the Advisory Committee on Immunization Practices from the process put in place to make changes to CDC vaccine recommendations.

US doctors still bouncing back from COVID-era burnout

Physician burnout rates continue to fall, and the healthy trend comes alongside strong and stable rates of physician job satisfaction.

To optimize infection-control practices, know your providers’ priorities

Demonstrated cost-effectiveness is a highly motivating factor in getting healthcare workers to adopt measures for preventing and controlling healthcare-associated infections.

ACIP panel given new guidance to shape vaccine recommendations

The shift comes after a federal court struck down sweeping changes to the pediatric vaccine schedule that went into effect in 2026. The committee of medical experts, which advises on policy at the Centers for Disease Control and Prevention (CDC), will have to focus on a cost-benefit analysis in its future analyses.

Trends in telemedicine utilization from 2019-2024 for all Americans, Americans without atherosclerotic cardiovascular disease (ASCVD), and Americans With ASCVD.

How telehealth utilization among heart patients has evolved since the pandemic

The COVID-19 pandemic created a major shift in how telehealth services were being utilized. Those services were used much more often for some patient populations than others.

ACIP meeting postponed after judge pauses RFK’s new vaccine recommendations

Judge Brian Murphy with the U.S. District Court of Massachusetts sided with the American Academy of Pediatrics and other plaintiffs who challenged the authority of HHS Secretary Robert F. Kennedy Jr to effectively remove the Advisory Committee on Immunization Practices from the process put in place to make changes to CDC vaccine recommendations.

A ‘disquieting plateau’: Healthcare costs are up, but survival among heart patients stays the same

The cardiovascular mortality rate in the United States decreased dramatically from 2000 to 2011. Since then, however, it has remained relatively unchanged.

Moderna, FDA reach compromise to accelerate approval of mRNA flu vaccine

The dispute centered around the pharmaceutical company's request for the shot to be approved for those aged 65 and over, a demographic the FDA argued was not properly represented in a 40,000-person clinical study. The company has agreed to perform additional research after the shot goes to market, having appeased regulators with safety data.

COVID-19 medical imaging examples of various clinical presentations. SARS-CoV-2 clinical imaging presentations.

PHOTO GALLERY: What does acute COVID-19 and long COVID look like on medical imaging?

This image gallery shows what the various clinical presentations associated with the COVID-19 and long COVID that have been documented during and after coronavirus pandemic.